Cancer BiologybioRxivPreprint
A targetable opioid/cancer associated fibroblast axis drives extracellular matrix remodeling and tumor aggressiveness in pancreatic cancer
Kathryn E. Maraszek, Arwen A. Tisdale, Hunter D. Reavis…·Michael E. Feigin
This study identifies an opioid-mediated signaling axis in pancreatic cancer that drives extracellular matrix remodeling and tumor aggressiveness, suggesting methylnaltrexone as a potential therapeutic.
1 citation